This healthcare professional guide contains important safety information regarding insulin degludec (Tresiba®), a basal insulin for the treatment of diabetes mellitus in adults, adolescents and children from 1 year.

The document provides important safety information regarding insulin degludec (Tresiba®), a basal insulin for the treatment of diabetes mellitus in adults, adolescents and children from 1 year. Tresiba® is introduced in two strengths — 100 units/mL and 200 units/mL — in the UK. As with all other insulin products, it is important not to risk mixing up different insulin strengths and this document provides information about this.

The document provides important safety information regarding insulin degludec (Tresiba®), a basal insulin for the treatment of diabetes mellitus in adults, adolescents and children from 1 year. Tresiba® is introduced in two strengths — 100 units/mL and 200 units/mL — in the UK. As with all other insulin products, it is important not to risk mixing up different insulin strengths and this document provides information about this.